Michael F. Giordano serves as Executive at RAPT Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael F. Giordano has executed 8 insider transactions totaling $634.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 30, 2026 involved receiving (via award) 4,956 shares valued at $0.
Michael F. Giordano currently holds 4,956 shares of RAPT Therapeutics, Inc. (RAPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael F. Giordano has been a net seller of RAPT stock. They have purchased $0 and sold $634.5K worth of shares.
Michael F. Giordano's most recent insider trade was on Jan 30, 2026, when they sold 4,956 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 12, 2022 | EPZM | $0 | Disposition | 8,060 | $N/A | Discretionary |
| May 17, 2022 | EPZM | $0 | Award | 8,994 | $N/A | Discretionary |
| Jun 11, 2021 | EPZM | $0 | Award | 8,060 | $N/A | Discretionary |
| Jun 25, 2020 | RAPT | $107.3K | Option Exercise | 8,944 | $12.00 | Discretionary |
| Jun 25, 2020 | RAPT | $62.2K | Option Exercise | 10,069 | $6.18 | Discretionary |
| Jun 25, 2020 | RAPT | $634.5K | Sale | 19,013 | $33.37 | Discretionary |